RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $610,974 | -57.8% | 26,651 | -69.7% | 0.00% | – |
| Q2 2023 | $1,448,630 | -3.4% | 87,849 | +4.5% | 0.00% | -100.0% |
| Q1 2023 | $1,499,934 | -73.1% | 84,077 | -56.0% | 0.00% | -50.0% |
| Q4 2022 | $5,569,636 | +1702.5% | 191,265 | +1413.8% | 0.00% | – |
| Q3 2022 | $309,000 | +896.8% | 12,635 | +68.3% | 0.00% | – |
| Q2 2022 | $31,000 | +416.7% | 7,507 | +1401.4% | 0.00% | – |
| Q1 2022 | $6,000 | -99.4% | 500 | -99.5% | 0.00% | – |
| Q4 2021 | $1,034,000 | -2.3% | 103,580 | +27.9% | 0.00% | – |
| Q3 2021 | $1,058,000 | -32.5% | 80,970 | +1.1% | 0.00% | -100.0% |
| Q2 2021 | $1,568,000 | -41.9% | 80,119 | -36.8% | 0.00% | 0.0% |
| Q1 2021 | $2,698,000 | -10.3% | 126,850 | +25.4% | 0.00% | 0.0% |
| Q4 2020 | $3,007,000 | +228.3% | 101,151 | +139.4% | 0.00% | – |
| Q3 2020 | $916,000 | +18220.0% | 42,257 | +17077.6% | 0.00% | – |
| Q2 2020 | $5,000 | -94.4% | 246 | -95.8% | 0.00% | – |
| Q1 2020 | $89,000 | +122.5% | 5,825 | +234.6% | 0.00% | – |
| Q4 2019 | $40,000 | -94.7% | 1,741 | -95.0% | 0.00% | – |
| Q3 2019 | $755,000 | +4341.2% | 34,972 | +4525.9% | 0.00% | – |
| Q2 2019 | $17,000 | +240.0% | 756 | +306.5% | 0.00% | – |
| Q1 2019 | $5,000 | -98.2% | 186 | -98.2% | 0.00% | – |
| Q4 2018 | $279,000 | +92.4% | 10,364 | +109.1% | 0.00% | – |
| Q3 2018 | $145,000 | +81.2% | 4,956 | +93.1% | 0.00% | – |
| Q2 2018 | $80,000 | +321.1% | 2,567 | +172.2% | 0.00% | – |
| Q1 2018 | $19,000 | -92.6% | 943 | -89.3% | 0.00% | – |
| Q4 2017 | $257,000 | – | 8,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |